Complement Activation

• 

  Subject Areas on Research

  • A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation. 
  • Acute vascular rejection and accommodation: divergent outcomes of the humoral response to organ transplantation. 
  • Adenovirus capsid-display of the retro-oriented human complement inhibitor DAF reduces Ad vector-triggered immune responses in vitro and in vivo. 
  • Aging and stress-induced changes in complement activation and neutrophil mobilization. 
  • An auto-anti-M causing hemolysis in vitro. 
  • Anaphylactic and anaphylactoid reactions. A review. 
  • Antibody-dependent enhancement of SIV infection: further characterization and cross reactivity between macaque and sooty mangabey isolates. 
  • Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. 
  • Behçet's disease patients present high levels of deglycosylated anti-lipoteichoic acid IgG and high IL-8 production after lipoteichoic acid stimulation. 
  • Beyond Viral Neutralization. 
  • C1-esterase inhibitor and a novel peptide inhibitor improve contractile function in reperfused skeletal muscle. 
  • CD19 can regulate B lymphocyte signal transduction independent of complement activation. 
  • Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD. 
  • Clinical relevance and IgG subclass determination of non-HLA antibodies identified using endothelial cell precursors isolated from donor blood. 
  • Complement activation and cardiac surgery: a novel target for improving outcomes. 
  • Complement activation contributes to perioperative neurocognitive disorders in mice. 
  • Complement factor H variant increases the risk of age-related macular degeneration. 
  • Complement mediates binding and procoagulant effects of ultralarge HIT immune complexes. 
  • Complement system in lung transplantation. 
  • Complement-Mediated Regulation of Apolipoprotein E in Cultured Human RPE Cells. 
  • Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis. 
  • Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. 
  • Complement-mediated release of fibroblast growth factor 2 from human RPE cells. 
  • Component deficiencies. 5. The fifth component. 
  • Diagnosis and treatment of anaphylactic/anaphylactoid reactions. 
  • Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. 
  • Dual islet transplantation modeling of the instant blood-mediated inflammatory reaction. 
  • Effect of Anti-C5a Therapy in a Murine Model of Early/Intermediate Dry Age-Related Macular Degeneration. 
  • Effect of pexelizumab in coronary artery bypass graft surgery with extended aortic cross-clamp time. 
  • Effects of chronic mild stress on serum complement activity, saccharin preference, and corticosterone levels in Flinders lines of rats. 
  • Enhanced CDC of B cell chronic lymphocytic leukemia cells mediated by rituximab combined with a novel anti-complement factor H antibody. 
  • Epidemiology, pathophysiology and clinical presentation of gram-negative sepsis. 
  • Generation of a fibroblast chemotactic factor in serum by activation of complement. 
  • Genetic therapies for xenotransplantation. 
  • Glycosyl phosphatidylinositol-linked blood group antigens and paroxysmal nocturnal hemoglobinuria. 
  • Human complement factor H Y402H polymorphism causes an age-related macular degeneration phenotype and lipoprotein dysregulation in mice. 
  • IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model. 
  • Inhaled asbestos activates a complement-dependent chemoattractant for macrophages. 
  • Innate networking: Thrombotic microangiopathy, the activation of coagulation and complement in the sensitized kidney transplant recipient. 
  • Inter-alpha-trypsin inhibitor attenuates complement activation and complement-induced lung injury. 
  • Intramolecular immunological signal hypothesis revived--structural background of signalling revealed by using Congo Red as a specific tool. 
  • Leishmania species: mechanisms of complement activation by five strains of promastigotes. 
  • Lymphocyte phenotypes in wild-caught rats suggest potential mechanisms underlying increased immune sensitivity in post-industrial environments. 
  • Microparticles as autoantigens: making immune complexes big. 
  • Multiple hyperacute rejections in the absence of detectable complement activation in a patient with endothelial cell reactive antibody. 
  • Neuroinflammation after surgery: from mechanisms to therapeutic targets. 
  • Next-generation computational genetic analysis: multiple complement alleles control survival after Candida albicans infection. 
  • Novel Immunoassay for Complement Activation by PF4/Heparin Complexes. 
  • Novel adenovirus vectors 'capsid-displaying' a human complement inhibitor. 
  • Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival. 
  • Regulation of humoral immune responses by CD21/CD35. 
  • Role of complement activation in obliterative bronchiolitis post-lung transplantation. 
  • Role of complement and Fc receptors in the pathogenesis of HIV-1 infection. 
  • Studies of complement-activating antibodies in the SIV/macaque model of acute primary infection and vaccine protection. 
  • Swine lungs expressing human complement-regulatory proteins are protected against acute pulmonary dysfunction in a human plasma perfusion model. 
  • Systemic Complement Activation in Donation After Brain Death Versus Donation After Circulatory Death Organ Donors. 
  • Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma. 
  • The Host Response to Viral Infections Reveals Common and Virus-Specific Signatures in the Peripheral Blood. 
  • The genome of the sea urchin Stongylocentrotus purpuratus 
  • The human gene for mannan-binding lectin-associated serine protease-2 (MASP-2), the effector component of the lectin route of complement activation, is part of a tightly linked gene cluster on chromosome 1p36.2-3. 
  • The immune consequences of trauma. 
  • The inflammatory response to cardiopulmonary bypass. 
  • The pathogenesis of dermatitis herpetiformis. 
  • The role of human CD46 in early xenoislet engraftment in a dual transplant model. 
  • The third component of complement: covalent attachment of a radioactive sugar to the labile binding site of C3 via the alternative pathway. 
  • V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144. 
  • Venous gas emboli and complement activation after deep repetitive air diving. 
  • Whole Recombinant Saccharomyces cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients With Solid Tumors Bearing Ras Mutations: Results From a Phase 1 Trial. 
• 

  Keywords of People

  • Ali, Hakim Azfar, Associate Professor of Medicine, Medicine, Pulmonary, Allergy, and Critical Care Medicine
  • Kelsoe, Garnett H., James B. Duke Distinguished Professor of Immunology, Immunology
  • Wray, Gregory Allan, Professor of Biology, Evolutionary Anthropology